Last updated on June 2019

Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases


Brief description of study

This study is to find out if administration of stereotactic radiosurgery (SRS) given after Nivolumab will improve overall response rate/anti-tumor activity in patients with metastatic breast cancer with brain metastases.

Clinical Study Identifier: NCT03807765

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.